Investor profile
Phil Morle
Accelerator, Venture capital & Partner at Main Sequence, School of Science - Advisory Board at University of Sydney Union (USU)
Phil Morle works as a Partner at Main Sequence. The firm's known portfolio counts 10 companies.
Is Phil Morle a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- FoodHardwareHealthcare
- Focus
- AerospaceAlt ProteinBiotechFoodTechSpaceStudent-Founded
Contacts
Affiliated funds' portfolios
Partner at Main Sequence, whose known portfolio counts 10 companies
- The EVERY Company
- Gilmour Space Technologies
- Advanced Navigation
- MGA Thermal
- Kasada
- Cauldron Ferm
- Arlula
- Breaker
- DeteQt
- Number 8 Bio
School of Science - Advisory Board at University of Sydney Union (USU), whose known portfolio counts 3 companies
- DeteQt
- Kinoxis Therapeutics
- Algenie
Investor Profile
Founders in the listed sectors Food, Hardware and Healthcare, and focus areas Aerospace, Alt Protein, Biotech and FoodTech fall inside that listing.
Main Sequence appears in Growth, Pre-Seed and Seed rounds across its known deals.
The firm portfolio and the focus above give founders context on whether Phil Morle matches their raise.
Colleagues
Mike Zimmerman
Co-founder and Partner
Sydney, Australia
Danielle Haj-Moussa
Investment Manager
Sydney, Australia
Jun Qu
Principal
Sydney, Australia
Alezeia Brown
Principal
Australia
Gabrielle Munzer
Partner
Melbourne, Australia
Bill Bartee
Managing Partner
Sydney, Australia
Alison Deans
Member of Investment Committee
Sydney, Australia
Erika Enberg
Director
Sydney, Australia
Martin Duursma
Partner
Sydney, Australia
Frequently asked questions
Who is Phil Morle?
Phil Morle is an accelerator partner and venture capital investor based in Sydney, New South Wales, Australia, listed as Partner at Main Sequence. The known portfolio of that firm counts 10 companies. That portfolio belongs to the firm, not to Phil Morle personally.
What does Phil Morle invest in?
Listed sectors include Food, Hardware and Healthcare; listed focus areas include Aerospace, Alt Protein, Biotech and FoodTech. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Phil Morle invest at?
Main Sequence appears in Growth, Pre-Seed and Seed rounds across its known deals, and Phil Morle is listed there as Partner. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Phil Morle listed at?
Phil Morle is listed as Partner at Main Sequence. 9 other people in the database share a firm with Phil Morle.
How do I contact Phil Morle?
An email address and a LinkedIn page are on file for Phil Morle. The address stays masked on this page and is readable inside RaiseHunt after you create an account. The database holds no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal